New Ray Medicine International Holding Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was HKD 50.15 million compared to HKD 89.77 million a year ago. Net loss was HKD 22.17 million compared to HKD 77.95 million a year ago.

Basic loss per share from continuing operations was HKD 0.0133 compared to HKD 0.0466 a year ago.